HTG Molecular Diagnostics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. HTG Molecular Diagnostics regular Real Value cannot be determined due to lack of data. The prevalent price of HTG Molecular Diagnostics is $0.0. Our model calculates the value of HTG Molecular Diagnostics from analyzing the firm fundamentals such as Return On Equity of -3.43, return on asset of -0.62, and Current Valuation of 2.56 M as well as examining its technical indicators and probability of bankruptcy.
HTG Molecular Total Value Analysis
HTG Molecular Diagnostics is currently forecasted to have valuation of 2.56 M with market capitalization of 1.06 M, debt of 4.83 M, and cash on hands of 14.1 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the HTG Molecular fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
2.56 M | 1.06 M | 4.83 M | 14.1 M |
HTG Molecular Investor Information
The company recorded a loss per share of 17.1. HTG Molecular Diagnostics last dividend was issued on the 23rd of November 2020. The entity had 1:12 split on the 21st of December 2022. Based on the analysis of HTG Molecular's profitability, liquidity, and operating efficiency, HTG Molecular Diagnostics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.HTG Molecular Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. HTG Molecular has an asset utilization ratio of 35.81 percent. This suggests that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that HTG Molecular Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.HTG Molecular Ownership Allocation
HTG Molecular retains 6.54 (percent) of its outstanding shares held by insiders and 0.74 (percent) owned by outside corporations.HTG Molecular Profitability Analysis
The company reported the previous year's revenue of 6.37 M. Net Loss for the year was (21.59 M) with loss before overhead, payroll, taxes, and interest of (2.01 M).HTG Molecular Growth Indicators
Investing in growth stocks can be very risky. If the company such as HTG Molecular does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 889.3 K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in HTG Stock
If you are still planning to invest in HTG Molecular Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HTG Molecular's history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |